Monday, January 9, 2017
Lantern Pharma has reached an agreement to collaborate with India-based AI and data analytics company, Intuition Systems. Lantern Pharma is a privately held, global biotech company pioneering the field of precision oncology. Lantern’s proprietary approach to drug development is driven by advanced genomics and machine learning-based artificial intelligence (AI), which when combined, are advancing a new wave of precision drug therapies that significantly reduce the time to market and overall risk associated with drug development. Intuition will work closely with Lantern’s existing computational team to bring additional AI, big data analysis, cloud support and infrastructure to support drug development and biomarker identification.